Emergent BioSolutions | EBS - 現金と同等





現金と同等 変化する 日付
Acadia Pharmaceuticals USD 976.45M 19.97M 2026-09
Akebia Therapeutics USD 159.25M 3.71M 2026-09
ALKERMES USD 631.31M 119.78M 2026-09
Alnylam Pharmaceuticals USD 1.75B 46.02M 2026-09
Amarin USD 156.51M 12.95M 2026-09
ANI Pharmaceuticals USD 420.76M 60.55M 2026-09
BioMarin Pharmaceutical USD 736.01M 138M 2026-09
Coherus Biosciences USD 82.92M 32.32M 2026-06
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Exelixis USD 304.77M 23.33M 2026-09
Glaxosmithkline GBP 2.93B 508M 2026-09
Heron Therapeutics USD 20.72M 5.4M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Ironwood Pharmaceuticals USD 86.38M 7.25M 2026-09
Lexicon Pharmaceuticals USD 38.09M 3.76M 2026-03
Lonza CHF 719M 188M 2025-12
Merck USD 9.55B 2.7B 2026-09
Moderna USD 1.72B 185M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Neurocrine Biosciences USD 641.5M 309.1M 2026-09
Pacira USD 1.79B 1.58B 2026-09
Pfizer USD 1.82B 848M 2026-09
PTC Therapeutics USD 508.89M 540.99M 2026-09
Sanofi EUR 6.35B 806M 2026-06
Sarepta Therapeutics USD 472.76M 98.39M 2026-09
United Therapeutics USD 1.19B 614.3M 2026-09
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12